mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.098 |
0.08 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.08 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.08 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.08 |
mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.08 |
mRNA |
BRD4132 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.09 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.09 |
mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.09 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.09 |
mRNA |
gossypol |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.09 |